CJC-1295
CJC-1295 is a 30-amino acid GHRH analog with DAC technology (CAS 863288-34-0) at 99.0% HPLC-verified purity. Extended plasma half-life for sustained GH and IGF-1 secretion research.
CJC-1295 — Research Summary
CJC-1295 is a tetrasubstituted 30-amino acid peptide hormone analog of GHRH (growth hormone-releasing hormone). Modified with drug affinity complex (DAC) technology in some formulations, it exhibits an extended plasma half-life compared to native GHRH. Research has focused on its role in stimulating GH and IGF-1 secretion with once or twice-weekly dosing schedules. Often studied alongside Ipamorelin to examine synergistic effects on GH pulse amplitude and frequency. For laboratory research use only.
Researchers Also Study
For research use only. Not for human or animal consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm these products will be used solely for lawful laboratory research.